| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -331.9% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 28.6 | n/a |
| Pr/Book | 6.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 129.3% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-10 | 0.12 | (0.83) | (0.18)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-11 | 0.28 | (0.94) | (0.19)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| License agreement signed with Bayer | 24-May-2012 | 07:00 | RNS |
| Far East Sales Commence | 08-May-2012 | 07:00 | RNS |
| Annual Financial Report | 27-Mar-2012 | 09:33 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1.40p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 3.63p |
| 52 Week Low | 1.20p |
| Volume | 182,613 |
| Shares Issued | 577.02m |
| Market Cap | £8.08m |
| Beta | 0.04 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:50 | 172,060 @ 1.44p |
| 11:34 | 5,000 @ 1.44p |
| 10:36 | 553 @ 1.44p |
| 08:00 | 5,000 @ 1.44p |
| Finance Director | Michael Anthony Bretherton |
| CEO | Nigel Theobald |
You are here: research